IL231448A0 - Phosphatidylinositol 3 - kinase inhibitors for the treatment of cancer - Google Patents
Phosphatidylinositol 3 - kinase inhibitors for the treatment of cancerInfo
- Publication number
- IL231448A0 IL231448A0 IL231448A IL23144814A IL231448A0 IL 231448 A0 IL231448 A0 IL 231448A0 IL 231448 A IL231448 A IL 231448A IL 23144814 A IL23144814 A IL 23144814A IL 231448 A0 IL231448 A0 IL 231448A0
- Authority
- IL
- Israel
- Prior art keywords
- phosphatidylinositol
- cancer
- treatment
- kinase inhibitors
- kinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161534836P | 2011-09-14 | 2011-09-14 | |
| US201161543529P | 2011-10-05 | 2011-10-05 | |
| US201161562670P | 2011-11-22 | 2011-11-22 | |
| PCT/US2012/055387 WO2013040337A1 (en) | 2011-09-14 | 2012-09-14 | Phosphatidylinositol 3-kinase inhibitors for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL231448A0 true IL231448A0 (en) | 2014-04-30 |
Family
ID=46940622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL231448A IL231448A0 (en) | 2011-09-14 | 2014-03-11 | Phosphatidylinositol 3 - kinase inhibitors for the treatment of cancer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2755654A1 (en) |
| KR (1) | KR20140077911A (en) |
| AU (1) | AU2012308414A1 (en) |
| BR (1) | BR112014005858A2 (en) |
| CA (1) | CA2848724A1 (en) |
| IL (1) | IL231448A0 (en) |
| IN (1) | IN2014CN02671A (en) |
| TW (1) | TW201325592A (en) |
| UY (1) | UY34339A (en) |
| WO (1) | WO2013040337A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113754565B (en) * | 2021-11-09 | 2022-02-22 | 南京威凯尔生物医药科技有限公司 | Method for preparing Shakubaqu intermediate in continuous flow microreactor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US7019002B2 (en) | 2001-12-11 | 2006-03-28 | Pharmacia & Upjohn, S.P.A. | Pyridopyrimidinones derivatives as telomerase inhibitors |
| CA2623768C (en) * | 2005-10-07 | 2016-04-12 | Exelixis, Inc. | N-(3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| WO2007044481A1 (en) | 2005-10-07 | 2007-04-19 | Basf Corporation | Clearcoat coating composition |
| NZ594628A (en) | 2005-10-07 | 2013-04-26 | Exelixis Inc | PYRIDOPYRIMIDINONE INHIBITORS OF PI3Ka |
| ME00937B (en) * | 2007-04-11 | 2012-06-20 | Exelixis Inc | Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer |
| WO2010146391A1 (en) * | 2009-06-15 | 2010-12-23 | Generics [Uk] Limited | Regioselective synthesis of letrozole |
| WO2012065057A2 (en) * | 2010-11-12 | 2012-05-18 | Exelixis, Inc. | Phosphatidylinositol 3-kinase inhibitors and methods of their use |
-
2012
- 2012-09-14 AU AU2012308414A patent/AU2012308414A1/en not_active Abandoned
- 2012-09-14 WO PCT/US2012/055387 patent/WO2013040337A1/en active Application Filing
- 2012-09-14 TW TW101133789A patent/TW201325592A/en unknown
- 2012-09-14 EP EP12766542.0A patent/EP2755654A1/en not_active Withdrawn
- 2012-09-14 KR KR1020147009539A patent/KR20140077911A/en not_active Application Discontinuation
- 2012-09-14 CA CA2848724A patent/CA2848724A1/en not_active Abandoned
- 2012-09-14 UY UY0001034339A patent/UY34339A/en not_active Application Discontinuation
- 2012-09-14 IN IN2671CHN2014 patent/IN2014CN02671A/en unknown
- 2012-09-14 BR BR112014005858A patent/BR112014005858A2/en not_active Application Discontinuation
-
2014
- 2014-03-11 IL IL231448A patent/IL231448A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140077911A (en) | 2014-06-24 |
| WO2013040337A1 (en) | 2013-03-21 |
| CA2848724A1 (en) | 2013-03-21 |
| AU2012308414A1 (en) | 2014-05-01 |
| BR112014005858A2 (en) | 2017-06-13 |
| UY34339A (en) | 2013-04-30 |
| EP2755654A1 (en) | 2014-07-23 |
| TW201325592A (en) | 2013-07-01 |
| WO2013040337A9 (en) | 2014-04-03 |
| IN2014CN02671A (en) | 2015-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200017I1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| HK1243919A1 (en) | Treatment of cancer with tor kinase inhibitors | |
| HK1207861A1 (en) | Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1 | |
| HRP20171474T1 (en) | Triazolopyrazines as brd4 inhibitors for use in the treatment of cancer | |
| PT3418281T (en) | Compounds useful as inhibitors of atr kinase for the treatment of cancer diseases | |
| AP3847A (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases | |
| HK1210174A1 (en) | Serine threonine kinase inhibitors for the treatment of hyperproliferativediseases | |
| HK1193823A1 (en) | Chromenone compounds as pi 3 -kinase inhibitors for the treatment of cancer pi3- | |
| HK1185874A1 (en) | Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer 4--n-- | |
| SG10201502566SA (en) | Use of novel pan-cdk inhibitors for treating tumors | |
| HK1205500A1 (en) | Kinase inhibitors for the treatment of cancer | |
| EP2897607A4 (en) | Inhibitors of beta-hydrolase for treatment of cancer | |
| WO2012037553A9 (en) | Use of pkc-iota inhibitors for the treatment of breast cancer | |
| IL231448A0 (en) | Phosphatidylinositol 3 - kinase inhibitors for the treatment of cancer | |
| AU2012901199A0 (en) | Kinase inhibitors for the Treatment of Cancer | |
| HK1202118A1 (en) | Piperazinyl derivatives for the treatment of cancer |